SCHEDULE 13G/A

Keros Therapeutics Inc

Common Stock, $0.0001 par value per share · CUSIP: 492327101

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• ExodusPoint Capital Management, LP

  Shares: 13,360 · Class: 0.04%

• ExodusPoint Capital Partners GP, LLC

  Shares: 13,360 · Class: 0.04%

• Michael Gelband

  Shares: 13,360 · Class: 0.04%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.